February 11, 2009 7:08 PM
- Text
Spending On Medical Research Soars
(AP)
Total U.S. spending on medical research has doubled in the past decade to nearly $95 billion a year, though whether the money is being well spent needs much better scrutiny, a study has found.
The report in Wednesday's Journal of the American Medical Association comes amid heightened public attention to medical research because of liability lawsuits over the painkiller Vioxx, political debate over stem cell research and the untapped potential of curing or preventing disease through mapping the human genome.
"If we're soon going to be spending $100 billion a year, we'd better have treatments that work over a long period of time against diseases that are important today and will be more important tomorrow," said Dr. Hamilton Moses III, co-author of the study and chairman of the Alerion Institute, which conducts studies on research policy.
"If we don't know those conditions are satisfied, we can't judge whether we're getting our money's worth," he said.
The study is part of a special issue of JAMA devoted to the state of U.S. medical research. What emerges from the issue is a picture of an amorphous, mostly profit-driven system, where industry research focuses on existing drugs and lets discovery-stage research lag behind.
The authors call on the medical industry, government and foundations to do better at investing in research on diseases with fewer effective treatments, such as Alzheimer's, and at translating basic research into new treatments and cures.
The authors have ties to the industry, medical schools and health companies, doing consulting work and sitting on drug company boards, according to financial disclosures published with the study.
The report in Wednesday's Journal of the American Medical Association comes amid heightened public attention to medical research because of liability lawsuits over the painkiller Vioxx, political debate over stem cell research and the untapped potential of curing or preventing disease through mapping the human genome.
"If we're soon going to be spending $100 billion a year, we'd better have treatments that work over a long period of time against diseases that are important today and will be more important tomorrow," said Dr. Hamilton Moses III, co-author of the study and chairman of the Alerion Institute, which conducts studies on research policy.
"If we don't know those conditions are satisfied, we can't judge whether we're getting our money's worth," he said.
The study is part of a special issue of JAMA devoted to the state of U.S. medical research. What emerges from the issue is a picture of an amorphous, mostly profit-driven system, where industry research focuses on existing drugs and lets discovery-stage research lag behind.
The authors call on the medical industry, government and foundations to do better at investing in research on diseases with fewer effective treatments, such as Alzheimer's, and at translating basic research into new treatments and cures.
The authors have ties to the industry, medical schools and health companies, doing consulting work and sitting on drug company boards, according to financial disclosures published with the study.
- 1
- 2
- Next Page »
Popular Now in Health
- Electronic cigarette explodes in man's mouth
- Skin cancer self-exam: What to look for (PHOTOS)
- Report: 400 types of lipstick contain lead
- Whitney Houston's autopsy: What's taking so long?
- All infant Tylenol recalled by J&J
- Christina Hendricks: Too Big for Hollywood?
- Things You Didn't Know About Your Penis
- Anti-Rape Condoms Fight World Cup Sex Assault
- PICTURES: 15 Shocking Sexual Fetishes
- HealthPop: Indulging, diagnosing and dying
- 8 Tips For Losing Weight After Pregnancy
- Caffeine inhalers - the next club drug?
- Heart Attack Grill owner responds to incident
- Cancer drug reverses Alzheimer's in mice: Study
- Mars to set calorie limit on chocolate bars
- New study is wake-up call for diet soda drinkers
- Orgasm Just by Thinking: Medically Possible?
Latest CBS News Headlines
on Facebook Most Discussed Stories
on CBS News
- Medco Health Solutions 4Q profit climbs 12 percent
- US-SKorea free trade pact to take effect in March
- Embrace risk, but only over the long haul
- Retirement tips: Here's how to save more now
on Facebook Most Discussed Stories
on CBS News






